Portfolio Building Block World Pharma and Biotech Index ETF
Portfolio Building Block World Pharma and Biotech Index ETF reported 52 holdings worth US$952M as of Jul 31, 2026 (Form N-PORT)
As of Jul 31, 2026 · Filed Sep 21, 2026
Portfolio Building Block World Pharma and Biotech Index ETF reported 52 holdings worth US$952M as of Jul 31, 2026. Largest: Eli Lilly And Company, Johnson & Johnson and Abbvie Inc. Filed Sep 21, 2026 (Form N-PORT).
- Holdings
- 52
- Value as reported
- US$952M
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|
| Eli Lilly And Company | 126K | US$145M | 15.2% |
| Johnson & Johnson | 359K | US$92M | 9.7% |
| Abbvie Inc. | 264K | US$66.1M | 6.9% |
| Merck & Company, Inc. | 368K | US$48M | 5.0% |
| Amgen Inc. | 115K | US$44.1M | 4.6% |
| Novartis Ag | 272K | US$42.6M | 4.5% |
| Astrazeneca Plc | 218K | US$37.1M | 3.9% |
| Gilead Sciences, Inc. | 276K | US$35.9M | 3.8% |
| Novo Nordisk A/s Class B | 708K | US$33.4M | 3.5% |
| Pfizer, Inc. | 1.27M | US$31.7M | 3.3% |
| Bristol-myers Squibb Company | 453K | US$29.6M | 3.1% |
| Vertex Pharmaceuticals Incorporated | 56,247 | US$26.8M | 2.8% |
| Gsk Plc | 828K | US$21.5M | 2.3% |
| Sanofi Sa | 241K | US$20.7M | 2.2% |
| Regeneron Pharmaceuticals, Inc. | 22,298 | US$17M | 1.8% |
| Bayer Ag | 218K | US$12.1M | 1.3% |
| Takeda Pharmaceutical Co. Ltd. | 344K | US$11.9M | 1.3% |
| Argenx Se | 12,756 | US$11.8M | 1.2% |
| Csl Limited | 122K | US$10.6M | 1.1% |
| Teva Pharmaceutical Industries Limited | 269K | US$9.13M | 0.96% |
| Natera, Inc. | 30,087 | US$8.06M | 0.85% |
| Sandoz Group Ltd | 90,803 | US$7.38M | 0.78% |
| Revolution Medicines, Inc. | 39,316 | US$7.37M | 0.77% |
| Zoetis Inc. | 93,270 | US$7.21M | 0.76% |
| Illumina, Inc. | 33,633 | US$6.9M | 0.72% |
| Ucb S.a. | 26,737 | US$6.86M | 0.72% |
| Biogen Inc. | 32,847 | US$6.67M | 0.70% |
| Otsuka Holdings Co., Ltd. | 91,224 | US$6.36M | 0.67% |
| Chugai Pharmaceutical Co., Ltd. | 139K | US$6.05M | 0.64% |
| Haleon Plc | 1.24M | US$6.05M | 0.64% |
| Alnylam Pharmaceuticals, Inc. | 29,349 | US$6.03M | 0.63% |
| Daiichi Sankyo Company, Limited | 365K | US$5.89M | 0.62% |
| Incyte Corporation | 44,808 | US$5.36M | 0.56% |
| Astellas Pharma Inc. | 385K | US$5.33M | 0.56% |
| United Therapeutics Corporation | 9,404 | US$4.87M | 0.51% |
| Royalty Pharma Plc | 83,179 | US$4.86M | 0.51% |
| Merck Kgaa | 28,653 | US$4.72M | 0.50% |
| Insmed Incorporated | 46,715 | US$4.61M | 0.48% |
| Viatris Inc. | 257K | US$4.51M | 0.47% |
| Moderna, Inc. | 78,235 | US$4.29M | 0.45% |
| Genmab A/s | 13,254 | US$3.79M | 0.40% |
| Neurocrine Biosciences, Inc. | 22,193 | US$3.7M | 0.39% |
| Roivant Sciences Ltd. | 107K | US$3.64M | 0.38% |
| Jazz Pharmaceuticals Plc | 13,582 | US$3.43M | 0.36% |
| Elanco Animal Health Incorporated | 113K | US$2.97M | 0.31% |
| Roche Holding Ltd | 6,832 | US$2.96M | 0.31% |
| Shionogi & Co., Ltd. | 160K | US$2.93M | 0.31% |
| Exelixis, Inc. | 54,638 | US$2.9M | 0.30% |
| Bridgebio Pharma, Inc. | 32,623 | US$2.61M | 0.27% |
| Galderma Group Ag | 11,886 | US$2.58M | 0.27% |
| Biomarin Pharmaceutical Inc. | 42,787 | US$2.57M | 0.27% |
| Ionis Pharmaceuticals, Inc. | 33,908 | US$1.76M | 0.18% |
Source
View original at SEC
Related